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Abstract 
Recent data indicate that serum Hsp70 (HSPA1A) levels are increased in type 1 and type 2 
diabetes mellitus. However, there is no report in the literature on circulating Hsp70 levels in 
gestational diabetes mellitus. In this pilot study, we measured serum Hsp70 levels in 11 
pregnant women with pregestational diabetes, 38 women with gestational diabetes and 40 
healthy pregnant women with ELISA. Plasma glucose levels, serum insulin concentrations, 
HbA1c values and the Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) index 
were also determined. According to our results, serum Hsp70 concentrations were 
significantly higher in women with pregestational and gestational diabetes mellitus than in 
healthy pregnant women. In addition, pregestational diabetic women had significantly higher 
Hsp70 levels than those with gestational diabetes. Furthermore, in the group of women with 
gestational diabetes mellitus, serum Hsp70 levels showed a significant positive correlation 
with HbA1c values. However, there was no other relationship between clinical features and 
metabolic parameters of the study subjects and their serum Hsp70 levels in either study group. 
In conclusion, we demonstrated for the first time in the literature that serum Hsp70 levels are 
increased and correlate with HbA1c values in women with gestational diabetes mellitus. 
Nevertheless, further studies are needed to determine whether circulating Hsp70 plays a 
causative role in the pathogenesis of gestational diabetes or elevated serum Hsp70 levels are 
only consequences of the disease. 
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Introduction 
Gestational diabetes mellitus (GDM) is a carbohydrate intolerance resulting in 
hyperglycaemia of variable severity with an onset or first recognition during pregnancy 
(Alberti and Zimmet 1998). GDM affects 3-5% of pregnant women and it is associated with 
an increased maternal and perinatal morbidity and mortality (Ben-Haroush et al. 2004). GDM 
mothers have an increased risk of preeclampsia, urinary tract infections, caesarean section, as 
well as type 2 diabetes mellitus later in life (Casey et al. 1997; Kim et al. 2002; Yogev et al. 
2004). Perinatal complications include macrosomia, polyhydramnios, shoulder dystocia with 
birth trauma, neonatal metabolic disturbances and perinatal death (Casey et al. 1997; Dudley 
2007; Hod et al. 1991). To determine whether GDM is present in pregnant women, the World 
Health Organization recommends screening between 24 and 28 weeks of gestation by means 
of a 75-gram oral glucose tolerance test (OGTT) (Alberti and Zimmet 1998). There is an 
increasing body of evidence that insulin resistance caused by high levels of several 
diabetogenic hormones produced by the placenta plays a central role in the pathogenesis of 
GDM (Dahlgren 2006). The development of GDM is influenced by both genetic and 
environmental risk factors, suggesting its multifactorial inheritance (Shaat and Groop 2007). 
Heat shock proteins (Hsps) are ubiquitous and phylogenetically conserved molecules, 
which indicate their functional importance. They are usually considered to be intracellular 
proteins with molecular chaperone and cytoprotective functions (Hightower 1991). However, 
70 kDa heat shock protein (Hsp70, HSPA1A) is present in the peripheral circulation of 
healthy non-pregnant individuals (Pockley et al. 1998). As HSPA1A is the most inducible 
form of the Hsp70 superfamily, we have chosen to study this protein. We have previously 
reported that serum Hsp70 levels are significantly lower in healthy pregnant than in healthy 
non-pregnant women (Molvarec et al. 2007b). In addition, we observed increased circulating 
Hsp70 concentrations in women with preeclampsia (Molvarec et al. 2006), as well as in 
pregnant asthmatics (Tamasi et al. 2010). Furthermore, we demonstrated that serum Hsp70 
levels are significantly higher in patients with the syndrome of hemolysis, elevated liver 
enzymes, and low platelet count (HELLP syndrome) than in severely preeclamptic patients 
without HELLP syndrome (Molvarec et al. 2007a). 
Recent data indicate that serum Hsp70 levels are increased in type 1 and type 2 
diabetes mellitus (Morteza et al. 2013; Nakhjavani et al. 2012; Nakhjavani et al. 2010; 
Nakhjavani et al. 2011; Oglesbee et al. 2005). However, there is no report in the literature on 
circulating Hsp70 levels in gestational diabetes mellitus. The aim of the present study was to 
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determine serum Hsp70 (HSPA1A) levels in pregnant women with pregestational diabetes, 
women with gestational diabetes and healthy pregnant women. We also examined whether 
parameters of carbohydrate metabolism are related to circulating Hsp70 levels in order to 
evaluate the involvement of this protein in the pathophysiology of gestational diabetes 
mellitus. 
 
Materials and methods 
 
Study participants 
 Eleven pregnant women with pregestational diabetes, 38 women with gestational 
diabetes and 40 healthy pregnant women with a normal oral glucose tolerance test were 
involved in our case-control study. The study participants were enrolled in the 1
st
 Department 
of Obstetrics and Gynecology at the Semmelweis University, Budapest, Hungary, between 
January 2004 and January 2006. All women were Caucasian and resided in the same 
geographic area in Hungary. The women were fasting, none were in active labor, and none 
had rupture of amniotic membranes. 
 Gestational diabetes mellitus was diagnosed with 75-gram oral glucose tolerance test 
(OGTT) using the World Health Organization criteria (Alberti and Zimmet 1998). Blood 
samples were taken before and 120 minutes after the glucose load (0 and 120 minutes). All 
women in the healthy pregnant control group had normal carbohydrate tolerance. Women in 
the pregestational diabetes group had diabetes mellitus before pregnancy and all of them were 
on insulin treatment. 
 The study protocol was approved by the Regional and Institutional Committee of 
Science and Research Ethics of the Semmelweis University, and written informed consent 
was obtained from each patient. The study was conducted in accordance with the Declaration 
of Helsinki. 
 
Biological samples 
Maternal blood samples were obtained from an antecubital vein into native tubes, as 
well as tubes containing sodium fluoride and disodium EDTA, and centrifuged at room 
temperature with a relative centrifugal force of 3000 g for 10 minutes. The aliquots of serum 
were stored at -80 °C until the measurement of Hsp70 levels. For haemoglobin A1c (HbA1c) 
determination, EDTA-anticoagulated whole blood was used. In the healthy pregnant and 
GDM groups, blood samples were taken when OGTT was performed (at 0 minutes). 
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Laboratory methods 
Serum Hsp70 levels were measured by using the ELISA Kit of R&D Systems 
(DYC1663E, Minneapolis, Minnesota, USA). Ninety six well microtiter plates were coated 
with mouse anti-human Hsp70 capture antibodies (100 μl; 2 μg/ml) in carbonate buffer (pH 
9.5) overnight at 4 °C. Plates were washed with PBS containing 0.1% Tween 20 three times 
and non-specific binding sites blocked by incubation with 200 μl of PBS containing 0.5% 
gelatine and Tween 20 for 1 hour at room temperature. After washing, 100 μl of the reference 
preparation (recombinant human Hsp70, 0-10 ng/ml) or samples (1:1) were added and the 
plates were incubated for 2 hours at room temperature. Plates were subsequently washed and 
Hsp70 binding was determined using biotinylated rabbit anti-human antibodies (100 μl; 0.5 
μg/ml) in PBS gelatine. After 1.5 hours at room temperature, plates were washed and 
incubated with streptavidin-HRP (horseradish-peroxidase, 1:200) in PBS gelatine for 20 
minutes at room temperature. Plates were washed and 100 μl of o-phenylene-diamine (OPD, 
Sigma, St. Louis, Missouri, USA) in citrate buffer was added. The optical density was 
measured at λ=490 nm (reference at λ=620 nm). The detection range of the assay was 0.05-10 
ng/ml, the intra/inter-assay variability <10/<16%, respectively. 
Plasma glucose levels were determined by the GOD-PAP method using Glucose 
Liquicolor reagent (Human Diagnostics, Wiesbaden, Germany, Cat. No. 10260) on a 
BioSystems A25 chemistry analyzer (ByoSystems, Barcelona, Spain). Serum insulin 
concentrations were measured by electrochemiluminescence immunoassay (ECLIA) by an 
autoanalyzer (Cobas 6000, Roche, Mannheim, Germany) using the manufacturer’s kits. 
HbA1c values were determined by high-performance liquid chromatography (HPLC) using the 
Variant™ II Turbo Haemoglobin Testing System (Bio-Rad Laboratories, Hercules, 
California, USA) according to the manufacturer’s instructions. The Homeostatic Model 
Assessment-Insulin Resistance (HOMA-IR) index was calculated as follows: (fasting glucose 
(mmol/l) x fasting insulin (mU/l)) / 22.5. 
 
Statistical analysis 
 The normality of continuous variables was assessed using the Shapiro-Wilk’s W-test. 
As the continuous variables were not normally distributed, nonparametric statistical methods 
were used. To compare continuous variables between two groups, the Mann-Whitney U-test 
was applied, whereas to compare them among multiple groups, the Kruskal-Wallis analysis of 
variance by ranks test was performed. Multiple comparisons of mean ranks for all groups 
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were carried out as post-hoc tests. As serum levels of Hsp70 showed skewed distributions, we 
performed analyses of covariance (ANCOVA) with logarithmically transformed data. The 
Spearman rank order correlation was carried out to calculate correlation coefficients. The 
scatterplot was created, as a nonparametric method, with logarithmically transformed values 
of the dependent variable. 
Statistical analyses were carried out using the following software: STATISTICA 
(version 12; StatSoft, Inc., Tulsa, Oklahoma, USA) and Statistical Package for the Social 
Sciences (version 22 for Windows; SPSS, Inc., Chicago, Illinois, USA). For all statistical 
analyses, p<0.05 was considered statistically significant. 
In the article, data are reported as median (interquartile range) for continuous 
variables. 
 
Results 
 
Patient characteristics and metabolic parameters 
 The clinical characteristics of the study participants are shown in Table 1. There were 
no statistically significant differences in pre-pregnancy body mass index (BMI), gestational 
age at delivery and fetal birth weight among the three study groups. However, maternal age 
was significantly higher in women with gestational diabetes than in healthy pregnant women 
and women with pregestational diabetes. In addition, the gestational age at blood sampling 
was significantly lower in the group of women with gestational diabetes mellitus than in the 
control group. Birth trauma or congenital malformation was not observed in our study groups. 
 Metabolic parameters of women with gestational and pregestational diabetes mellitus 
are presented in Table 2. In pregestational diabetic women, fasting plasma glucose, HbA1c, 
fasting serum insulin and HOMA-IR values were significantly higher than in women with 
gestational diabetes mellitus. 
 
Serum heat shock protein 70 (Hsp70, HSPA1A) levels 
 Serum levels of Hsp70 (HSPA1A) in our study groups are demonstrated in Figure 1. 
Serum Hsp70 concentrations were significantly higher in women with pregestational (0.39 
(0.33-0.45) ng/ml, p<0.001) and gestational diabetes mellitus (0.28 (0.24-0.35) ng/ml, 
p<0.05) than in healthy pregnant women (0.26 (0.20-0.30) ng/ml). Furthermore, 
pregestational diabetic women had significantly higher Hsp70 levels than those with 
gestational diabetes (p<0.05). The differences in serum Hsp70 levels between the study 
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groups remained significant even after adjustment for maternal age, pre-pregnancy BMI and 
gestational age at blood draw in analysis of covariance (adjusted mean ± standard error of log 
(serum Hsp70 concentration (ng/ml)): -0.63 ± 0.03 in normal pregnancy, -0.51 ± 0.03 in 
GDM and -0.42 ± 0.05 in pregestational diabetes; p<0.05). 
We also investigated whether the clinical characteristics and metabolic parameters of 
the study participants were related to their serum Hsp70 levels by calculating the Spearman 
rank order correlation coefficients. In the group of women with gestational diabetes mellitus, 
serum Hsp70 levels showed a significant positive correlation with HbA1c values (Spearman 
R=0.37, p<0.05; Figure 2). However, there was no other relationship between clinical features 
and metabolic parameters of the study subjects and their serum Hsp70 levels in either study 
group. 
 
Discussion 
 In this pilot study, we determined serum Hsp70 (HSPA1A) levels in pregnant women 
with pregestational diabetes, women with gestational diabetes and healthy pregnant women. 
According to our results, serum Hsp70 concentrations were significantly higher in women 
with pregestational and gestational diabetes mellitus than in healthy pregnant women. In 
addition, pregestational diabetic women had significantly higher Hsp70 levels than those with 
gestational diabetes. Furthermore, in the group of women with gestational diabetes mellitus, 
serum Hsp70 levels showed a significant positive correlation with HbA1c values. 
A growing number of studies demonstrate that circulating Hsp70 levels are elevated in 
type 1 and type 2 diabetes mellitus (Morteza et al. 2013; Nakhjavani et al. 2012; Nakhjavani 
et al. 2010; Nakhjavani et al. 2011; Oglesbee et al. 2005). Inflammation and oxidative stress, 
characteristic features of diabetes mellitus, have been suggested to account for the increase in 
serum Hsp70 concentrations in these disorders. Indeed, oxidative stress has been implicated in 
the exercise-induced circulating Hsp70 response and the supplementation with vitamin C and 
the vitamin E isoform γ-tocopherol completely blunted this response (Fischer et al. 2006). 
Interestingly, Hsp70 levels in peripheral blood mononuclear cells were found to be elevated 
reflecting increased oxidative stress in patients with type 2 diabetes (Yabunaka et al. 1995). 
Additionally, a significant up-regulation of Hsp70 has been detected in peripheral blood 
lymphocytes from type 2 diabetic patients with and without nephropathy, representing a 
maintained response in counteracting the systemic pro-oxidant status (Calabrese et al. 2012; 
Calabrese et al. 2007). It is noteworthy that peripheral blood mononuclear cells are capable of 
releasing Hsp70 into the extracellular space (Hunter-Lavin et al. 2004a). Furthermore, the 
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antioxidant folic acid, which reduces oxidative stress in vivo, significantly decreased serum 
Hsp70 levels in non–insulin-treated type 2 diabetes patients (Hunter-Lavin et al. 2004b). 
Inflammatory mediators and oxidative stress have also been implicated in the 
pathogenesis of gestational diabetes mellitus (Ategbo et al. 2006; Lappas et al. 2011; Winkler 
et al. 2002). Therefore, it is tempting to speculate that increased serum Hsp70 levels in 
gestational diabetes observed in this study reflect – at least in part – systemic inflammation 
and oxidative stress. Indeed, we have previously demonstrated that increased serum Hsp70 
concentrations in women with preeclampsia are related to pro-inflammatory changes in 
circulating cytokine profile, as well as to serum C-reactive protein and plasma 
malondialdehyde levels (Molvarec et al. 2009; Molvarec et al. 2011). Further studies are 
required to determine the relationship between serum Hsp70 levels and markers of 
inflammation and oxidative stress in women with GDM. 
Hyperglycaemia is another candidate to be responsible for the increase in serum 
Hsp70 concentrations in pregnant women with pregestational diabetes and GDM. Certainly, 
circulating Hsp70 levels paralleled changes in serum glucose levels in diabetic ketoacidosis, 
suggesting that hyperglycaemia might induce the release of Hsp70 from hepatosplanchnic 
viscera (Oglesbee et al. 2005). In addition, serum levels of Hsp70 markedly increased after 
glucose ingestion in non-obese Black pregnant women (Jaffe et al. 2013). In an experimental 
model, serum Hsp70 levels were significantly higher in pregnant rats with severe than in those 
with mild diabetes possessing lower blood glucose levels (Saito et al. 2013). Interestingly, we 
observed a significant positive correlation between serum Hsp70 concentrations and HbA1c 
values in women with GDM, suggesting that chronic hyperglycaemia might contribute to the 
elevation in serum Hsp70 levels observed in GDM. Our finding that circulating Hsp70 
concentrations are significantly higher in pregnant women with pregestational diabetes than in 
those with GDM is consistent with previous data demonstrating that serum Hsp70 levels are 
associated with the duration of diabetes, especially in women (Nakhjavani et al. 2010; 
Nakhjavani et al. 2011). 
Adipose tissue expansion has also been linked to elevated circulating Hsp70 levels in 
diabetes. In a previous study, plasma Hsp70 levels were observed to be increased only in 
obese but not in non-obese type 2 diabetic patients as compared to obese controls (Rodrigues-
Krause et al. 2012). However, the authors did not involve non-obese controls in their study. 
There were significant positive correlations between logarithmic-transformed serum Hsp70 
concentrations and BMI values in patients with long-standing diabetes, in those with newly 
diagnosed disease, as well as in healthy controls in another study (Nakhjavani et al. 2010). 
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These data are at variance with our results, as we did not find any association between BMI 
values and serum Hsp70 levels in pregnant women with pregestational or gestational diabetes, 
or in healthy pregnant women. Nevertheless, the majority of our study participants were of 
normal weight. 
Elevated circulating Hsp70 level may not only be a marker of gestational diabetes 
mellitus, but might also play a role in its pathogenesis. Extracellular Hsp70 derived from 
stressed and damaged, necrotic cells can act as an intercellular stress signalling molecule, 
representing an ancestral danger signal of a non-physiological condition, such as cellular 
stress or damage, to elicit innate and adaptive proinflammatory immune responses (Pockley 
2003). Extracellular Hsp70 acts through binding to surface receptors (CD14, CD36, CD40, 
CD91, LOX-1, Toll-like receptor 2 and 4) on antigen-presenting cells, stimulating their 
proinflammatory cytokine (tumor necrosis factor-α (TNF-α), interleukin (IL)-1β and IL-6) 
and chemokine production, as well as costimulatory molecule expression (Asea 2005; Asea et 
al. 2000; Asea et al. 2002; Basu et al. 2001). Therefore, it is possible that circulating Hsp70 
may contribute to the development of systemic inflammation observed in gestational diabetes 
mellitus. Indeed, increased circulating Hsp70 levels have already been revealed to be 
associated with inflammatory responses in several pathological conditions, such as in acute 
infections, after liver resection and coronary artery bypass grafting, as well as following 
myocardial infarction (Dybdahl et al. 2005; Dybdahl et al. 2002; Kimura et al. 2004; Njemini 
et al. 2003). Furthermore, although intracellular Hsp70 may combat insulin resistance (Bruce 
et al. 2003; Chung et al. 2008; Kavanagh et al. 2011; Kurucz et al. 2002; McCarty 2006; 
Simar et al. 2012), extracellular Hsp70 has recently been shown to correlate with insulin 
resistance in vivo and to cause pancreatic β-cell dysfunction and death in vitro (Krause et al. 
2014). However, we did not observe any relationship between circulating Hsp70 
concentrations and serum insulin levels or HOMA-IR values in our study groups. 
Nevertheless, the lack of association between increased serum Hsp70 levels and 
clinical features and metabolic parameters of pregnant women with pregestational or 
gestational diabetes may also be due to genetic variations in Hsp70 production, release into 
the extracellular space or stability. Additionally, Hsp70, with its intrinsic ability to act as a 
chaperone, can bind to other macromolecules, which might mask its detection by ELISA. 
Moreover, as all women in the pregestational diabetes group were on insulin treatment, serum 
insulin levels and HOMA-IR values are not useful to determine insulin resistance in this 
group. 
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 In conclusion, we demonstrated for the first time in the literature that serum Hsp70 
levels are increased and correlate with HbA1c values in women with gestational diabetes 
mellitus. However, additional studies are needed to determine whether circulating Hsp70 
plays a causative role in the pathogenesis of gestational diabetes or elevated serum Hsp70 
levels are only consequences of the disease. 
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Table 1. Clinical characteristics of the study participants 
 
 Normal pregnancy 
(n=40) 
Gestational diabetes 
(n=38) 
Pregestational diabetes 
(n=11) 
Age (years) 30 (28-32) 33 (29-36)
a 
26 (24-33)
b 
Pre-pregnancy BMI (kg/m
2
) 21.9 (19.0-26.2) 23.3 (21.4-29.0) 22.3 (19.9-30.0)
 
Gestational age at blood draw 
(weeks) 
26 (24-28) 24 (23-25)
a 
25 (24-27)
 
Gestational age at delivery 
(weeks) 
39 (38-40) 38 (37-39) 38 (37-39)
 
Fetal birth weight (grams) 3350 (3050-3550) 3150 (2650-3380)
 
3400 (2700-3500)
 
 
 
Data are presented as median (25-75 percentile) 
BMI: body mass index 
 
a
 p<0.05 versus normal pregnancy 
b
 p<0.05 pregestational diabetes versus gestational diabetes 
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Table 2. Metabolic parameters of women with gestational and pregestational diabetes mellitus 
at time of blood draw for serum Hsp70 measurement 
 
 Gestational diabetes 
(n=38) 
Pregestational 
diabetes (n=11) 
Statistical significance 
(p value) 
Fasting plasma glucose (mmol/l) 4.8 (4.5-5.2) 5.6 (5.6-5.6)
 
<0.05 
OGTT 120 min (mmol/l) 8.7 (8.3-9.5) n.m.
 
 
HbA1c (%) 5.2 (5.1-5.6) 6.2 (5.7-7.0)
 
<0.001 
Fasting serum insulin (mU/l) 7.9 (4.8-13.5) 22.7 (16.0-34.7) <0.001 
HOMA-IR 1.8 (0.9-3.3) 5.6 (4.0-8.6)
 
<0.001 
 
 
Data are presented as median (25-75 percentile) 
n.m.: not measured; OGTT: 75-gram oral glucose tolerance test; Hb: haemoglobin; HOMA-
IR: Homeostatic Model Assessment-Insulin Resistance 
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Figure legends 
Figure 1 
Serum heat shock protein 70 (Hsp70, HSPA1A) levels of the study participants 
Middle line: median; Box: interquartile range (25-75 percentile); Whisker: range (excluding 
outliers); 
a
 p<0.05 versus normal pregnancy; 
b
 p<0.001 versus normal pregnancy; 
c
 p<0.05 
pregestational diabetes versus gestational diabetes 
 
Figure 2 
Scatterplot with linear fit and the regression line of logarithmically transformed values of 
serum heat shock protein 70 (Hsp70, HSPA1A) levels versus haemoglobin A1c (HbA1c) 
values in patients with gestational diabetes mellitus 
